Hosted on MSN10mon
Kardium’s pulsed field ablation clinical trial enters final stagesKardium has completed enrolment in a study evaluating its pulsed-field ablation (PFA) device for the treatment of atrial fibrillation. According to a ClinicalTrials.gov entry, the PULSAR trial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback